Health committee  As I said, we see the importance of distinguishing between what population-based screening programs do and a differentiated pathway for people who have an elevated and high risk. We hear from patients, and we've done a lot of work surveying patient groups. People are showing up at their family doctors with signs and symptoms and are being refused screening access within this group.

Health committee  If I could....

Health committee  It's just to add that we requested the task force to consider high-risk and elevated-risk guidelines in the current review. That's something else we would be looking to see. It's important to know that these screening programs are for average-risk populations. We need separate guidance for those at elevated and high risk.

Health committee  Thank you very much. I think you used the term “mixed messages”, and that's part of the challenge we're experiencing as a result of these guidelines. We have provinces and territories across Canada with different approaches to breast cancer screening. What that has inadvertently created is inequity: Where you live dictates what your breast cancer screening access looks like.

Health committee  Certainly, yes. The Canadian Cancer Society is very actively engaged with all provincial governments across Canada on this issue. We recognize that many provincial programs—

Health committee  Good morning. My name is Kelly Wilson Cull, and I'm the director of advocacy. With me today is Ciana Van Dusen, who's the advocacy manager of prevention and early detection. The Canadian Cancer Society is the voice for people who care about cancer in Canada. As a part of our commitment to improving and saving lives, we are pleased to provide recommendations on breast cancer screening.